News
Noteworthy news from Fidock lab
Small-Saunders joined the Fidock lab as a postdoc after finishing her infectious diseases fellowship at Columbia. Malaria parasites were becoming increasingly resistant to the antimalarial artemisinin and her goal was to learn how some parasites can evade the drug and use that information to help lead the way to new therapeutic strategies.
Read MoreThe Centers for Disease Control and Prevention has issued a health advisory following the recent cases of malaria in Florida and Texas.
So how worried should we be about malaria?
Read MoreIn this KSQA exclusive interview, Dr. Tania de Koning-Ward, Specialty Chief Editor at Frontiers in Cellular and Infection Microbiology, discusses the upcoming Keystone Symposia "Malaria: Confronting Challenges From Drug Discovery to Treatment" with meeting organizer Dr. David Fidock. The symposium, to be held in Breckenridge April 10-13, 2022, will bring together diverse players, from field-based clinician-investigators and modelers to experts in drug discovery and development, to collectively identify new approaches to overcome malaria drug resistance.
Read MoreMALARIA: CONFRONTING CHALLENGES FROM DRUG DISCOVERY TO TREATMENT
Read MoreDavid Fidock, PhD, FASTMH (Columbia University), discusses his career path, mentoring philosophy, future plans and advice for trainees and junior PIs.
Read MoreCongratulations Sachel and our coauthors on the publication of our K13 manuscript today in Nature Communications!
Read More
